Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Exp Immunol ; 172(2): 321-32, 2013 May.
Article in English | MEDLINE | ID: mdl-23574328

ABSTRACT

Probiotics are live microorganisms which have beneficial effects on the host when ingested in adequate amounts. Probiotic bacteria may stimulate immune effector functions in a strain-specific manner. In this blind placebo-controlled trial, we investigated the effects on the immune system following daily intake of six different strains of lactobacilli or the Gram-negative bacterium Pseudomonas lundensis for 2 or 5 weeks. Blood lymphocyte subsets were quantified by fluorescence activated cell sorter and the expression of activation and memory markers was determined. The bacterial strains were also examined for their capacity to adhere to human intestinal cells and to be phagocytosed by human peripheral blood mononuclear cells. Intake of Lactobacillus plantarum strain 299v increased the expression of the activation marker CD25 (P = 0·01) on CD8(+) T cells and the memory cell marker CD45RO on CD4(+) T cells (P = 0·03), whereas intake of L. paracasei tended to expand the natural killer T (NK T) cell population (P = 0·06). The phagocytic activity of granulocytes was increased following intake of L. plantarum 299v, L. plantarum HEAL, L. paracasei or L. fermentum. In contrast, ingestion of L. rhamnosus decreased the expression of CD25 and CD45RO significantly within the CD4(+) cell population. The observed immune effects after in-vivo administration of the probiotic bacteria could not be predicted by either their adherence capacity or the in-vitro-induced cytokine production. The stimulation of CD8(+) T cells and NK T cells suggests that intake of probiotic bacteria may enhance the immune defence against, e.g. viral infections or tumours.


Subject(s)
Intestinal Mucosa/immunology , Lactobacillus/immunology , Probiotics/pharmacology , Pseudomonas/immunology , Adolescent , Adult , Bacterial Adhesion , CD4-Positive T-Lymphocytes/immunology , CD4-Positive T-Lymphocytes/microbiology , CD8-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/microbiology , Female , Humans , Immunity, Cellular , Interleukin-10/analysis , Interleukin-12/analysis , Interleukin-2 Receptor alpha Subunit/metabolism , Intestinal Mucosa/microbiology , Leukocyte Common Antigens/metabolism , Leukocytes, Mononuclear/immunology , Leukocytes, Mononuclear/microbiology , Lymphocyte Activation/immunology , Lymphocyte Subsets/cytology , Male , Middle Aged , Natural Killer T-Cells/immunology , Natural Killer T-Cells/microbiology , Placebos , Probiotics/administration & dosage , Young Adult
2.
Microb Pathog ; 31(3): 151-8, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11500100

ABSTRACT

Protein D, having a glycerol-3-phosphodiester phosphodiesterase activity, is found at the surface of all Haemophilus influenzae strains and is a possible virulence factor. In the present study, the involvement of protein D in the entry of NTHi into human monocytic cells is reported. Primary monocytes and the monocytic cell lines U-937 and THP-1 were infected with NTHi strain 772 and the mutant 772 Delta hpd 1 (lacking the gene for protein D). NTHi 772 adhered to and entered monocytic cells up to four-fold more efficiently compared to 772 Delta hpd 1. When an Escherichia coli transformant expressing protein D was incubated with monocytic cells, the number of intracellular bacteria increased 1.6-fold compared to protein D-deficient controls. Any correlation between internalization and phosphorylcholine expression was not detected. In conclusion, our data suggest that surface-expressed protein D promotes the adherence of NTHi to human monocytes leading to a higher number of internalized bacteria.


Subject(s)
Bacterial Adhesion , Bacterial Proteins , Carrier Proteins/metabolism , Haemophilus influenzae/physiology , Immunoglobulin D , Lipoproteins/metabolism , Monocytes/metabolism , Monocytes/microbiology , Carrier Proteins/genetics , Escherichia coli/genetics , Escherichia coli/pathogenicity , Escherichia coli/physiology , Gene Deletion , Gene Expression Profiling , Gene Expression Regulation, Bacterial , Haemophilus influenzae/classification , Haemophilus influenzae/enzymology , Haemophilus influenzae/genetics , Humans , Lipoproteins/genetics , Phosphoric Diester Hydrolases/genetics , Phosphoric Diester Hydrolases/metabolism , Transformation, Bacterial , Tumor Cells, Cultured , U937 Cells , Virulence/genetics
3.
J Infect Dis ; 184(2): 150-8, 2001 Jul 15.
Article in English | MEDLINE | ID: mdl-11424011

ABSTRACT

Previous reports showed that nontypeable Haemophilus influenzae (NTHi) reside in macrophage-like cells in human adenoid tissue. This study investigated the ability of nonopsonized NTHi and encapsulated H. influenzae type b (Hib) to enter human monocytic and epithelial cells. The number of intracellular bacteria was determined by a viability assay and flow cytometry. To characterize the mechanisms responsible for the internalization of NTHi, different inhibitors of surface molecules, receptor turnover, and the cytoskeleton were used. Hib were found in monocytic cells at very low numbers (<100 bacteria/2x105 cells). In contrast, a great variation in intracellular numbers was detected between the different NTHi isolates (range, 0.0007%-0.28% of the inoculum for monocytes and 0.053%-3.5% for epithelial cells). NTHi entered human monocytic and epithelial cells via a receptor-mediated endocytosis involving mainly a beta-glucan receptor that could be blocked by laminarin.


Subject(s)
Epithelial Cells/metabolism , Haemophilus influenzae/metabolism , Monocytes/metabolism , Receptors, Cell Surface , Receptors, G-Protein-Coupled , Receptors, Immunologic/metabolism , Carcinoma/metabolism , Flow Cytometry , Fluorescence , Humans , Leukemia, Monocytic, Acute/metabolism , Lung Neoplasms/metabolism , Mannose/antagonists & inhibitors , Microscopy, Electron , Platelet Membrane Glycoproteins/antagonists & inhibitors , Receptors, Immunologic/antagonists & inhibitors , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL